AlphaSense
The $7.5 Billion Pre-IPO Deep Dive — $600M+ ARR growing ~40%, a content moat bought for $930M, and bankers reportedly in the room with no S-1 on file.
AlphaSense is the first research platform to turn the Bloomberg-terminal pricing umbrella into a growth SaaS business: $600M+ ARR in Q1 2026 (company-disclosed; reportedly $700M+ by July), growing roughly 40%, with 7,000+ customers including 70%+ of the S&P 500. The $7.5B June 2026 round prices it at ~12.5× ARR — a premium to FactSet's ~4.6× that is earned only if growth holds while the AI-disruption question is answered. The IPO setup is real: a capital-markets CFO, a channel partner in Accenture, and reported adviser engagement. But EDGAR shows nothing, profitability is undisclosed, and the company is still absorbing model-inference costs. This is a 2027 listing priced for 2026 enthusiasm.
The Numbers at a Glance
1 · Business Overview
Sixteen years from a search box to a research operating system
| Metric | Value |
|---|---|
| Founded | 2010 · New York |
| CEO | Jack Kokko (co-founder, ex-Morgan Stanley analyst) |
| CTO | Raj Neervannan (co-founder) |
| CFO | Samantha Greenberg · appointed April 14, 2026 to lead capital-markets strategy |
| HQ | Hudson Yards, New York (opened early 2026) |
| Employees | 2,000+ (company, 2025) · ~3,000 per third-party estimates, unverified |
| Disclosed Equity Raised | ~$1.74B across eight rounds (company says "well over $1B") |
| Current Valuation | $7.5B · June 3, 2026 growth round |
| Prior Valuation | $4.0B · June 2024 Series F ($650M) |
| ARR | $600M+ Q1 2026 (company) · $700M+ July 2026 (The Information, unconfirmed) |
| Growth Rate | ~40% YoY (CFO, July 2026) |
| International | 21% of ARR · APAC customers +50% YoY |
AlphaSense started as a semantic search engine for financial documents — the "Smart Synonyms" product that let an analyst find every mention of pricing pressure across 10-Ks without guessing the phrasing. Fifteen years of compounding turned that into a platform indexing 500M+ documents across broker research from 1,700+ sources, filings, transcripts, news, and — since the Tegus deal — the largest expert-call library in the market. The customer base is no longer just hedge funds: the company says more than 70% of the S&P 500, over half of the Fortune 500, and all of the world's top investment banks are customers.
2 · Product Suite & Moat
Proprietary content is the thing an LLM cannot scrape
| Product | Description | Strategic Role |
|---|---|---|
| Core Search & Monitoring | Semantic search across 500M+ docs, 37+ languages, alerts and dashboards | Revenue engine · seat-based |
| Generative Search / Grid | LLM answers with document-level citations; Grid runs one question across many documents | Usage flywheel · +33% QoQ query growth |
| Deep Research & SuperAnalyst | Agentic multi-step research (June 2025); always-on agent in early access (June 2026) | Agent-era positioning |
| Expert Insights (Tegus) | 280,000+ expert-call transcripts, 8,000+ added monthly; AI Agent Interviewer; Channel Checks | Proprietary content moat |
| Financial Data (Canalyst) | 4,500+ drivable models, 17,000+ companies, consensus, comps, KPIs, M&A and funding data | Terminal-replacement wedge |
| Enterprise Intelligence | Customer's internal documents indexed alongside external content; 20+ connectors | Corporate expansion · deals +185% YoY |
| Work Products | Native PowerPoint and Excel assistants (July 2026); Carousel acquisition (Oct 2025) | Output layer · retention |
The moat thesis rests on four pillars:
- Licensed content nobody else can assemble — Broker research from 1,700+ sources (including an exclusive aftermarket distribution deal with Goldman Sachs), plus Tegus transcripts the company spends "more than $100 million a year" to produce. A frontier model reading public filings cannot replicate a sell-side note or a primary-source expert interview.
- Compliance as a feature — 75+ compliance staff screen every expert call. For regulated buyers, the audit trail is the product; this is why hedge funds pay for Tegus rather than booking calls themselves.
- Distribution into the corporate suite — Enterprise Intelligence turns AlphaSense from an analyst tool into a corporate-strategy system, and the June 2026 Accenture channel partnership gives it a consulting sales force it never had.
- Gartner validation — Named a Leader, highest on both axes, in the April 2026 Magic Quadrant for Competitive & Market Intelligence Platforms — the procurement shortcut that unlocks Fortune 500 budgets.
3 · Financials & Unit Economics
$200M to $700M in 27 months — with visible deceleration
AlphaSense discloses ARR milestones rather than financial statements, which makes the growth curve legible but the margin structure opaque. ARR went from $200M+ in April 2024 to $400M+ in March 2025 (roughly doubling, helped by the consolidation of Tegus's estimated $100M+ ARR), then $500M+ in October 2025 and $600M+ in Q1 2026. The Information reported $700M+ in July 2026; the company has not confirmed that figure.
Three things the milestones tell you, and one they hide:
- Growth is decelerating from an acquisition-inflated base. April 2024 → March 2025 was ~100% with Tegus consolidated; March 2025 → Q1 2026 is ~50%; the CFO now guides to "about 40%". That is still elite for a $600M+ software business, but the public-market narrative will be the 40, not the 100.
- The customer count is compounding more slowly than ARR — 4,000+ (Sep 2023) → 5,000+ (end 2024) → 7,000+ (Q2 2026). Net revenue retention and price, not logo count, are carrying the growth — consistent with the shift to Enterprise Intelligence deals (+185% YoY) that run from five figures to "millions of dollars."
- International is under-penetrated at 21% of ARR — the headcount doubling in EMEA and APAC is the 2026–2027 growth lever.
- Profitability is undisclosed. The CFO has said the company is "absorbing a lot of" LLM token cost rather than pricing it through, and is moving to consumption pricing. Until an S-1 lands, gross margin is the single biggest unknown in the model.
The revenue-quality question: unlike a payments company, AlphaSense's ARR is genuinely recurring, seat- and enterprise-licensed, with a median contract reported around $17,500 and large deals above $1M. The risk is not collection; it is gross margin under AI inference costs and content-licensing costs (the $100M+ annual Tegus library spend alone is ~17% of ARR).
4 · IPO Status & Timeline
Every pre-IPO box ticked — except the filing
We checked EDGAR directly rather than relying on aggregator copy. AlphaSense, LLC (CIK 0001656191) has exactly one filing: a Form D from October 2015. There is no S-1 and no public draft registration statement. A confidential DRS would not be visible, so absence of evidence is not proof — but nothing credible asserts a filing exists either.
What does exist is the scaffolding. On April 14, 2026 the company appointed Samantha Greenberg (ex-CFO of ID.me, ex-Citadel and Goldman) as CFO explicitly "to lead capital markets strategy and investor engagement." On June 3, 2026 it raised $350M at $7.5B, and Kokko told Reuters: "while we can't comment on the exact timing, we believe the public markets represent a natural path for AlphaSense's growth journey." On July 23, 2026 The Information reported the company "has been working with advisers on a potential initial public offering in the coming months."
A growth round three months before "IPO steps" is a pre-IPO crossover, not a substitute for one
The critical nuance: unlike Stripe's tender cadence, AlphaSense's June round was small relative to valuation ($350M on $7.5B, ~4.7% dilution) and brought in crossover-style names — J.P. Morgan Asset Management, D. E. Shaw Ventures, Vitruvian — whose playbook is to mark the last private round near the IPO price. That is a pricing anchor, not a stay-private valve.
- The CFO hire came seven weeks before the round and was framed around capital markets from day one.
- Kokko's "natural path" language to Reuters is the most explicit any AlphaSense executive has been about listing.
- The Information's sourcing ("people with direct knowledge") on adviser engagement is credible; the "coming months" timing is the unverified part.
- Private liquidity is thin (four live orders on one platform, "not currently traded" on another) — there is no secondary market relieving employee pressure the way Stripe's tenders do.
Base case: confidential DRS in H2 2026, public flip and listing in H1 2027 at or above $7.5B. Bull case: a Q4 2026 listing if the software IPO window that reopened in 2026 holds. Bear case: a 2027 slip while the company proves margins under inference costs.
5 · Competitive Landscape
Squeezed from above by terminals, from below by AI-native challengers
| Competitor | Ticker | Revenue / ARR | Growth | Position |
|---|---|---|---|---|
| AlphaSense | Private | $600M+ ARR | ~40% | AI search + proprietary content |
| Bloomberg | Private | n/d · ~$28–33K/seat | n/d | Terminal incumbent, ~33% share (est.) |
| FactSet | FDS | $2.32B FY25 | +5.4% | Workstation + data feeds |
| S&P Global (Capital IQ) | SPGI | $14.2B FY24 (group) | ~+14% | Data + ratings + indices |
| Morningstar (PitchBook) | MORN | $2.28B FY24 | ~+12% | Private-market data |
| Rogo | Private | n/d · $2B val. | n/d | AI-native banking workflows |
| Hebbia | Private | n/d · ~$700M val. | n/d | AI document analysis |
| Perplexity Finance | Private | $450M+ ARR (all products) | n/d | Consumer-grade AI search |
Public-comp revenue is reported fiscal-year revenue; AlphaSense is ARR — not strictly like-for-like, but the gap in growth is the point: AlphaSense at ~40% is growing seven to eight times faster than FactSet and roughly three times faster than S&P Global's data businesses. The AI-native set (Rogo at $2B, Hebbia, Perplexity) has capital and velocity but none has disclosed ARR anywhere near AlphaSense's, and none owns a licensed-content library.
6 · Tegus & the Content Flywheel
The $930M acquisition that became the moat
From search engine to content owner
AlphaSense announced the $930M acquisition of Tegus on June 11, 2024 and closed it on July 8 — financed by the $650M Series F plus a senior secured credit facility arranged by Blue Owl whose size has never been disclosed. (AlphaSense had sued Tegus over patents before buying it — the same sue-then-acquire pattern it ran with Sentieo.)
What it bought: an expert-call library of 100,000+ transcripts at close, now 280,000+ and growing 8,000 a month; Canalyst's drivable financial models (now 4,500+); and BamSEC. The company says it invests "more than $100 million" a year in the library and staffs 75+ compliance professionals around it.
Why this matters for the IPO: every AI-native competitor can build a better chat interface. None can buy 280,000 compliance-screened primary-source interviews. Tegus converted AlphaSense from an application that could be disintermediated by a model into a content business with an AI front end — and the 2026 plan to "more than double" the library across APAC and EMEA is the international growth engine. The costs are the flip side: an 8% headcount cut followed the deal, and the credit facility sits on the balance sheet that an S-1 will have to show.
7 · Valuation Framework
12.5× ARR — between FactSet and MSCI, with growth to justify it
| Metric | Value | Comp |
|---|---|---|
| Valuation | $7.5B | — |
| ARR (Q1 2026, company) | $600M+ | — |
| Valuation / ARR | ~12.5× | ~10.7× on reported $700M |
| Market cap / revenue, public comps | — | MSCI ~14.4× · SPGI ~8.9× · TRI ~6.3× · FDS ~4.6× · MORN ~3.5× |
| Growth (ARR) | ~40% YoY | FDS +5% · SPGI ~+14% · MORN ~+12% |
| Growth-adjusted (multiple ÷ growth) | ~0.31× | FDS ~0.85× · MSCI ~1.1× · SPGI ~0.64× |
| Profitability | Undisclosed | Token costs currently absorbed |
On a growth-adjusted basis AlphaSense is the cheapest name on the chart — ~0.31× multiple-per-point-of-growth against 0.6–1.1× for the incumbents. The market is discounting two things: unproven margins and the possibility that 40% becomes 25% once AI-native rivals mature. Fair-value triangulation:
- Bull case ($10–12B): IPO prices on $800M+ forward ARR at 13–15× as growth holds near 40%, gross margin prints above 70% despite inference costs, and Enterprise Intelligence makes it a corporate-software story rather than a hedge-fund tool.
- Base case ($7.5–9B): Listing at or modestly above the June round; multiple settles at 10–12× NTM ARR as growth moderates to 30–35%.
- Bear case ($4–5B): IPO slips into 2027, a model-lab finance agent compresses seat pricing, and public investors apply FactSet-plus-growth math — 6–8× on ARR that is decelerating. Note that even the bear case sits above the June 2024 Series F.
8 · Key Risks
What public-market diligence will price in
| Risk | Severity | Mitigant |
|---|---|---|
| AI commoditization of research | High | Licensed broker research + 280K expert calls are not scrapeable; Gartner Leader position |
| Gross margin under inference costs | High | Shift to consumption pricing under way; no margin disclosure until S-1 |
| Content-licensing dependence | Medium | 1,700+ broker sources diversify; Goldman exclusive is a single-point asset |
| Tegus leverage & integration | Medium | Blue Owl facility undisclosed; 8% headcount cut already absorbed; library growing 8K/month |
| Growth deceleration | Medium | ~100% → ~50% → ~40%; international (21% of ARR) and corporate are fresh levers |
| Litigation overhang | Medium | AlphaSights trademark suits (US + Ireland); FT Partners fee dispute survived dismissal Jan 2026; Daloopa trade-secret case withdrawn |
| Hedge-fund budget cyclicality | Low–Medium | 70%+ of S&P 500 as customers dilutes buy-side concentration; mix undisclosed |
| Key-person | Low | Founder-CEO and CTO intact; CFO, CPO and CMO bench built for a public company |
9 · Pre-IPO Exposure Routes Today
Thin secondaries, no public proxy — patience is the main route
| Route | How | Caveats |
|---|---|---|
| Private secondary platforms | AlphaSense is listed on several accredited-investor marketplaces | Four live orders on one venue, "not currently traded" on another; no public round price per share |
| ACN | Accenture Ventures invested in the June round and Accenture is the first strategic channel partner | Immaterial to Accenture's P&L · sentiment exposure only |
| FDS (short comp) | Long AlphaSense IPO via a FactSet short — the seat-share loser thesis | Pairs-trade · FactSet buys back stock and grows ASV; execution risk |
| SPGI / MSCI / MORN | Own the category multiple the IPO will be priced against | No AlphaSense-specific exposure · category beta only |
| Patience | Wait for the S-1 flip and roadshow window | Cleanest entry · base case H1 2027 |
Bottom Line
AlphaSense is the most credible research-software IPO candidate of the cycle — $600M+ ARR growing ~40%, 7,000+ enterprise customers, and a licensed-content moat that a frontier model cannot scrape. The $7.5B June 2026 round is a crossover anchor, not a ceiling: on growth-adjusted multiples it is cheaper than every listed peer. What it is not is de-risked. There is no filing on EDGAR, profitability has never been disclosed, inference costs are being absorbed rather than priced, and growth is visibly decelerating from a Tegus-inflated base. The IPO is the catalyst and the S-1 is the test: a gross margin above 70% with 35%+ growth prints a $10B+ listing; anything less hands the pricing to FactSet-plus-growth math. For growth portfolios, this is a high-conviction watchlist name — track the DRS flip, not the rumor cycle.